SCHEMBL3457356

SCHEMBL3457356

CCN1CN(C)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 3/20 0.42
MAPT P10636 3/20 0.42
GAA P10253 2/20 0.42
HPGD P15428 1/20 0.42
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
USP2 O75604 1/20 0.36
CDK4 P11802 1/20 0.36
ALOX15 P16050 1/20 0.36
CCND1 P24385 1/20 0.36
ALDH2 P05091 1/20 0.36
ALDH3A1 P30838 1/20 0.36
HSD17B3 P37058 1/20 0.36
CES1 P23141 3/20 0.35
BCHE P06276 1/20 0.35
MGLL Q99685 1/20 0.35
KDM1A O60341 2/20 0.35
CDC25A P30304 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30463973 1.00 ALDH1A1 (0.42) ALDH1A1KDM4EMAPTGAAHPGD
Iodide SCHEMBL9327210 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTGAAHPGD
Hydrochloric Acid SCHEMBL5144204 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTGAAHPGD
Bromide SCHEMBL9327220 0.98 ALDH1A1 (0.41) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL927716 0.86 HSD17B3 (0.40) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL3697070 0.85 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL11995108 0.84 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTGAAHPGD
Iodide SCHEMBL2821259 0.84 HSD17B3 (0.39) ALDH1A1KDM4EMAPTGAAMEN1
Iodide SCHEMBL1780085 0.84 HSD17B3 (0.39) ALDH1A1KDM4EMAPTGAAMEN1
Hydrochloric Acid SCHEMBL30935728 0.84 MEN1 (0.40) ALDH1A1KDM4EMAPTGAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0398358-B1 Aluminum electroplating method MITSUBISHI PETROCHEMICAL CO (JP) 1994-03-09 EP claimed
US-12612548-B2 Method for producing inorganic fluoride luminescent material NICHIA CORPORATION (JP) 2026-04-28 US disclosed
US-12291506-B2 Method for producing amidate compound, and amidate compound KOEI CHEMICAL COMPANY, LIMITED (JP) 2025-05-06 US disclosed
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-09-21 US disclosed
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent KOEI CHEMICAL COMPANY, LIMITED (JP) 2023-08-08 US disclosed
US-20230220275-A1 METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-07-13 US disclosed
CN-109563050-B Amide salt compound, catalyst for polyurethane production and method for producing polyurethane resin 广荣化学株式会社 2023-06-02 CN disclosed
US-20230142294-A1 PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL NICHIA CORPORATION (JP) 2023-05-11 US disclosed
CN-111094375-B Blocking agent dissociation catalyst for blocked isocyanate and thermosetting composition containing the same 广荣化学株式会社 2022-04-01 CN disclosed
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND KOEI CHEMICAL COMPANY, LIMITED (JP) 2022-02-17 US disclosed
US-9012899-B2 Electroluminescent metal complexes with nucleophilic carbene ligands BASF SE (DE) 2015-04-21 US disclosed
US-20150007963-A1 IONIC LIQUIDS FOR COOLING IN HIGH TEMPERATURE ENVIRONMENT VTU HOLDING GMBH (AT) 2015-01-08 US disclosed
EP-2809739-A1 IONIC LIQUIDS FOR COOLING IN HIGH TEMPERATURE ENVIRONMENT VTU Holding GmbH (AT) 2014-12-10 EP disclosed
US-20130292660-A1 ELECTROLUMINESCENT METAL COMPLEXES WITH NUCLEOPHILIC CARBENE LIGANDS BASF SE (DE) 2013-11-07 US disclosed
WO-2013113461-A1 IONIC LIQUIDS FOR COOLING IN HIGH TEMPERATURE ENVIRONMENT VTU HOLDING GMBH (AT) 2013-08-08 WO disclosed
US-20100321863-A1 ACTIVATED CARBON AND PROCESS FOR PRODUCING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-23 US disclosed
US-7785495-B2 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-08-31 US disclosed
EP-2093191-A1 ACTIVATED CARBON AND METHOD FOR PRODUCING THE SAME Sumitomo Chemical Company, Limited (JP) 2009-08-26 EP disclosed
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-04-23 US disclosed
EP-1905740-A1 ELECTRIC DOUBLE LAYER CAPACITOR Sumitomo Chemical Company, Limited (JP) 2008-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090103241-A1 Activated carbon prepared by carbonizing and activating a calixarene containing dihydroxybenzene rings; especially calcining at 400 degrees C. or less in the presence of an oxidative gas, calcining at 1500 degrees or less in an inactive gas, and then further calcining at 200-1500 degrees in H2O or CO2 CBR1, CYP24A1, CALU ALDH1A1 2159/4885KDM4E 2457/4885MAPT 4867/4885
US-12291506-B2 Method for producing amidate compound, and amidate compound NAAA, NIT2, PAM ALDH1A1 4082/4885KDM4E 4058/4885MAPT 2416/4885
US-20230295368-A1 CATALYST FOR DISSOCIATION OF BLOCKING AGENT FOR BLOCKED ISOCYANATES, AND THERMOSETTING COMPOSITION CONTAINING SAID CATALYST FOR DISSOCIATION OF BLOCKING AGENT IDH3A, RCOR1, MUS81 ALDH1A1 1038/4885KDM4E 429/4885MAPT 2132/4885
US-11718704-B2 Catalyst for dissociation of blocking agent for blocked isocyanates, and thermosetting composition containing said catalyst for dissociation of blocking agent IDH3A, RCOR1, MUS81 ALDH1A1 1038/4885KDM4E 429/4885MAPT 2132/4885
US-20220048864-A1 METHOD FOR PRODUCING AMIDATE COMPOUND, AND AMIDATE COMPOUND NAAA, NIT2, PAM ALDH1A1 4082/4885KDM4E 4058/4885MAPT 2416/4885
US-12612548-B2 Method for producing inorganic fluoride luminescent material FLNA, F7, NPM1 ALDH1A1 1047/4885KDM4E 2254/4885MAPT 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.